Merck Unveils $1.5 Billion Expansion In China With New Beijing R&D Center; Plans To Double R&D Team By 2014
This article was originally published in PharmAsia News
Executive Summary
While many Big Pharmas are cutting R&D budgets in response to patent cliffs, Merck is investing $1.5 billion in R&D in China, in what could be the largest ever pharma R&D investment in the country.